MediciNova, Inc.
Price Action
Technical Summary
CONSOLIDATINGMediciNova, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 57), indicating performance broadly in line with the market. Earnings growth of 10% provides fundamental context to the price action. Investors should exercise caution due to high volatility (67% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.32 | +9.13% | ABOVE |
| 50 SMA | $1.36 | +6.23% | ABOVE |
| 100 SMA | $1.40 | +2.77% | ABOVE |
| 150 SMA | $1.44 | -0.10% | BELOW |
| 200 SMA | $1.41 | +1.93% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is MNOV in an uptrend right now?
MNOV has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is MNOV overbought or oversold?
MNOV's RSI (14) is 62. The stock is in neutral territory, neither overbought nor oversold.
Is MNOV outperforming the market?
MNOV has a Relative Strength (RS) Rating of 57 out of 99. MNOV is performing about average compared to the market.
Where is MNOV in its 52-week range?
MNOV is trading at $1.44, which is 73% of its 52-week high ($1.96) and 34% above its 52-week low ($1.17).
How volatile is MNOV?
MNOV has a Beta of 0.26 and 52-week volatility of 67%. It's less volatile than the S&P 500 - generally more stable.